40912-26-3

Upstream product

• 23341-13-1 5-cyano-1,3-benzenedicarboxylic acid 

Relevant academic research and scientific papers

Amidoxime porous polymers for CO2 capture

CO2 capture from fossil fuel based electricity generation remains costly since new power plants with monoethanol amine (MEA) as the scrubbing agent are under construction. Amidoximes are known to mimic MEA, and porous polymers with amidoximes could offer a sustainable solution to carbon capture. Here we report the first amidoxime porous polymers (APPs) where aromatic polyamides (aramids) having amidoxime pendant groups were synthesized through low temperature condensation of 4,4′-oxydianiline (ODA) and p-phenylene diamine (p-PDA) with a new type of nitrile-bearing aromatic diacid chloride. The nitrile pendant groups of the polyamides were converted to an amidoxime functionality by a rapid hydroxylamine addition (APP-1 and APP-2). The CO2 adsorption capacities of these polyamides were measured at low pressure (1 bar) and two different temperatures (273 and 298 K) and high pressure (up to 225 bar-the highest measuring pressure to date) at 318 K. The low pressure CO2 uptake of APP-1 was found to be 0.32 mmol g -1 compared with APP-2 (0.07 mmol g-1) at 273 K, whereas at high pressure they showed a substantial increase in CO2 adsorption capacity exhibiting 24.69 and 11.67 mmol g-1 for APP-1 and APP-2 respectively. Both aramids were found to be solution processable, enabling membrane applications.

Novel methylselenoesters as antiproliferative agents

Selenium (Se) compounds are potential therapeutic agents in cancer. Importantly, the biological effects of Se compounds are exerted by their metabolites, with methylselenol (CH3SeH) being one of the key executors. In this study, we developed a new series of methylselenoesters with different scaffolds aiming to modulate the release of CH3SeH. The fifteen compounds follow Lipinski’s Rule of Five and with exception of compounds 1 and 14, present better drug-likeness values than the positive control methylseleninic acid. The compounds were evaluated to determine their radical scavenging activity. Compound 11 reduced both DPPH and ABTS radicals. The cytotoxicity of the compounds was evaluated in a panel of five cancer cell lines (prostate, colon and lung carcinoma, mammary adenocarcinoma and chronic myelogenous leukemia) and two non-malignant (lung and mammary epithelial) cell lines. Ten compounds had GI50 values below 10 μM at 72 h in four cancer cell lines. Compounds 5 and 15 were chosen for further characterization of their mechanism of action in the mammary adenocarcinoma cell line due to their similarity with methylseleninic acid. Both compounds induced G2/M arrest whereas cell death was partially executed by caspases. The reduction and metabolism were also investigated, and both compounds were shown to be substrates for redox active enzyme thioredoxin reductase.

Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum

Quinoline antimalarials target hemozoin formation causing a cytotoxic accumulation of ferriprotoporphyrin IX (Fe(III)PPIX). Well-developed SAR models exist for β-hematin inhibition, parasite activity, and cellular mechanisms for this compound class, but no comparably detailed investigations exist for other hemozoin inhibiting chemotypes. Here, benzamide analogues based on previous HTS hits have been purchased or synthesized. Only derivatives containing an electron deficient aromatic ring and capable of adopting flat conformations, optimal for π-π interactions with Fe(III)PPIX, inhibited β-hematin formation. The two most potent analogues showed nanomolar parasite activity, with little CQ cross-resistance, low cytotoxicity, and high in vitro microsomal stability. Selected analogues inhibited hemozoin formation in Plasmodium falciparum causing high levels of free heme. In contrast to quinolines, introduction of amine side chains did not lead to benzamide accumulation in the parasite. These data reveal complex relationships between heme binding, free heme levels, cellular accumulation, and in vitro activity of potential novel antimalarials.